<SEC-DOCUMENT>0001144204-15-071293.txt : 20160120
<SEC-HEADER>0001144204-15-071293.hdr.sgml : 20160120
<ACCEPTANCE-DATETIME>20151216165317
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-15-071293
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20151216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protalix BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001006281
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				650643773
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		2 SNUNIT ST
		STREET 2:		SCIENCE PARK, POB 455
		CITY:			CARMIEL
		STATE:			L3
		ZIP:			20100
		BUSINESS PHONE:		972-4-988-9488

	MAIL ADDRESS:	
		STREET 1:		2 SNUNIT ST
		STREET 2:		SCIENCE PARK, POB 455
		CITY:			CARMIEL
		STATE:			L3
		ZIP:			20100

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHODONTIX INC
		DATE OF NAME CHANGE:	19980422

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EMBASSY ACQUISITION CORP
		DATE OF NAME CHANGE:	19960124
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="image_001.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">December 16, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>VIA EDGAR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suzanne Hayes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Assistant Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Office of Healthcare and Insurance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporate Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mail Stop 4720</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, D.C. &nbsp;20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify"><U>Protalix BioTherapeutics, Inc., Registration Statement
on Form S-3</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><U>Filed November 13, 2015 and amended on November 27,
2015<BR>
File No. 333-208004</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Ms. Hayes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We refer to the registration statement on
Form S-3 (File No. 333-208004) (as amended, the &ldquo;Registration Statement&rdquo;) of Protalix BioTherapeutics, Inc., a Florida
corporation (the &ldquo;Company&rdquo;). In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company
hereby respectfully requests the acceleration of the effectiveness of the Registration Statement so that it may become effective
at 4:05 p.m. (Eastern time) on December 18, 2015 or as soon as practicable thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company hereby acknowledges that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">should the Securities and Exchange Commission
(the &ldquo;Commission&rdquo;) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not
foreclose the Commission from taking any action with respect to the filing; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: left; text-indent: -28.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">the action of the Commission or the staff,
acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility
for the adequacy and accuracy of the disclosure in the filing; and </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">the Company may not assert staff comments
and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We thank you in advance for your time and attention to the Registration
Statement. Should you wish to discuss the enclosed materials at any time, please do not hesitate to contact me at +972 (4) 902-8100
or YossiM@protalix.com or the Company&rsquo;s counsel, James R. Tanenbaum of Morrison &amp; Foerster LLP at +1 (212) 468-8163 or
jtanenbaum@mofo.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Yossi Maimon<BR>
<BR>
Yossi Maimon<BR>
Vice President and Chief Financial Officer<BR>
Protalix BioTherapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">cc:</TD><TD STYLE="text-align: justify">Moshe Manor</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Protalix BioTherapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0in; text-align: justify">James
R. Tanenbaum<BR>
Morrison &amp; Foerster LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">2 Snunit Street, Science Park P.O.B. 455,
Carmiel 20100, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Tel: 972-4-988-9488 | Fax: 972-4-988-9489
| Web: www.protalix.com&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  W *4# 2(  A$! Q$!_\0
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M44 :0 4    < "FM#$\BR/&C.OW6*@D?0T44 /J-8(4+%8HU+G+84#/UHHH
M>0"02!D=#Z48 ).!D]3110 TPQ&42F)#(.CE1D?C2NB2(5=593U##(-%% "@
..!5"J  . !VHHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
